Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: marks (231), grades (548)

Vinorelbine (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication Sec
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

InP-MATRix

Description: Chemotherapy Protocol LYMPHOMA MATRix – CYTARABINE-METHOTREXATE-RITUXIMAB-THIOTEPA Inpatient Regimen Regimen • Lymphoma – InP-MATRix – Cytarabine-Metho
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-MATRix.pdf

BEACOPP escalated

Description: Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-PREDNISOLONEPROCARBAZINE-VINCRISTINE (BEACOPP Escalated) Regimen • Lymphoma – BEACOPP Escalated -Bleomycin-Cy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/BEACOPP-escalated.pdf

Trabectedin v1

Description: Chemotherapy Protocol SARCOMA Regimen TRABECTEDIN Sarcoma-Trabectedin Indication Trabectedin is recommended as a possible treatment for people with advan
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Trabectedin-v1.pdf

DVd(Twice weekly)Daratumumab-Bortezomib-Dexamethasone Cycle 9 onwards

Description: Chemotherapy Protocol Myeloma Bortezomib (twice weekly) Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib (twice
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdTwice-weeklyDaratumumab-Bortezomib-Dexamethasone-Cycle-9-onwards.pdf

DVd Weekly Daratumumab-Bortezomib-Dexamethasone weekly Cycles 9 onwards

Description: Chemotherapy Protocol Myeloma DVd (weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 9 onwards) Regimen • Myeloma – Bortezomib (weekl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-weekly-Cycles-9-onwards.pdf

Recovering well after a LLETZ procedure under general anaesthetic - patient information

Description: This factsheet explains what to expect after having an operation known as a 'LLETZ procedure' (also known as a 'loop diathermy
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Recovering-well-after-a-LLETZ-procedure-under-general-anaesthetic-3049-PIL.pdf

Von Hippel-Lindau disease (VHL) - patient information

Description: Information about von Hippel-Lindau (VHL) disease.
Url: /Media/UHS-website-2019/Patientinformation/Genetics/Von-Hippel-Lindau-disease-VHL-1438-PIL.pdf

Declaration Rest of England and Wales

Description: Declaration of Result University Hospital Southampton NHS Foundation Trust Public -Rest of England and Wales As Returning Officer at the election
Url: /Media/UHS-website-2019/Images/Council-of-Governors/Rest-of-England-and-Wales/Declaration-Rest-of-England-and-Wales.pdf

University Hospital Southampton Copyright Notice_COV-Boost assets

Description: COV-BOOST TRIAL ASSETS COPYRIGHT NOTICE All video/audio/photographic outputs and/or interviews/case studies supplied on t
Url: /Media/Southampton-Clinical-Research/University-Hospital-Southampton-Copyright-Notice-COV-Boost-assets.pdf

491 to 500 of 1000

Previous … 48 49 50 51 52 … Next